Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Japanese generic major Nichi-Iko Pharmaceutical said on October 31 that it has won a patent infringement suit filed by Swiss-based Debiopharm International SA over the anticancer agent Elplat (oxaliplatin). In the suit, the Swiss drug maker claimed that a generic…
To read the full story
Related Article
- Top Court Dismisses Elplat Patent Infringement Case: Nichi-Iko
November 9, 2017
- Nippon Kayaku Prevails in Elplat Damage Suit: High Court
June 30, 2017
- Debiopharm’s Appeal on Elplat Patent Suit Dismissed: Nichi-Iko
May 8, 2017
- Sawai Prevails in Patent Suit over Elplat
December 26, 2016
- Nippon Kayaku Faces Damage Suit over Elplat Patent
May 17, 2016
- Towa Prevails in Patent Suit over Elplat
April 1, 2016
- Debiopharm Wins Elplat Patent Suit against Nippon Kayaku
March 8, 2016
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





